Tamara den Harink1,2, Nico A Blom3, Reinoud J B J Gemke4, Henk Groen5, Annemieke Hoek6, Ben W J Mol7, Rebecca C Painter8, Irene M Kuipers3, Tessa J Roseboom9,10,8, Arend W van Deutekom9,11. 1. Department Epidemiology and Data Science, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands. t.denharink@amsterdamumc.nl. 2. Amsterdam UMC, University of Amsterdam, Department(s), Amsterdam Reproduction & Development Research Institute, Amsterdam, the Netherlands. t.denharink@amsterdamumc.nl. 3. Department of Pediatric Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands. 4. Department of Pediatrics, Emma Children's Hospital Amsterdam UMC, Amsterdam, Amsterdam, the Netherlands. 5. Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. 6. Department of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. 7. Department of Obstetrics and Gynecology, Monash University, Clayton, Victoria, Australia. 8. Department of Obstetrics and Gynecology, Amsterdam UMC, Amsterdam Reproduction and Development, University of Amsterdam, Amsterdam, the Netherlands. 9. Department Epidemiology and Data Science, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands. 10. Amsterdam UMC, University of Amsterdam, Department(s), Amsterdam Reproduction & Development Research Institute, Amsterdam, the Netherlands. 11. Department of Pediatrics, Division of Paediatric Cardiology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.
Abstract
BACKGROUND: Improving maternal lifestyle before conception may prevent the adverse effects of maternal obesity on their children's future cardiovascular disease (CVD) risk. In the current study, we examined whether a preconception lifestyle intervention in women with obesity could alter echocardiographic indices of cardiovascular health in their children. METHODS: Six years after a randomized controlled trial comparing the effects of a 6-month preconception lifestyle intervention in women with obesity and infertility prior to fertility care to prompt fertility care, 315 of the 341 children conceived within 24 months after randomization were eligible for this study. The intervention was aimed at weight loss (≥5% or until BMI < 29 kg/m2). Children underwent echocardiographic assessment of cardiac structure and function, conducted by a single pediatric cardiologist, blinded to group allocation. Results were adjusted for multiple variables including body surface area, age, and sex in linear regression analyses. RESULTS: Sixty children (32 girls, 53%) were included, mean age 6.5 years (SD 1.09). Twenty-four children (40%) were born to mothers in the intervention group. Children of mothers from the intervention group had a lower end-diastolic interventricular septum thickness (-0.88 Z-score, 95%CI -1.18 to -0.58), a lower left ventricle mass index (-8.56 g/m2, 95%CI -13.09 to -4.03), and higher peak systolic and early diastolic annular velocity of the left ventricle (1.43 cm/s 95%CI 0.65 to 2.20 and 2.39 cm/s 95%CI 0.68 to 4.11, respectively) compared to children of mothers from the control group. CONCLUSIONS: Children of women with obesity, who underwent a preconception lifestyle intervention, had improved cardiac structure and function; a thinner interventricular septum, lower left ventricle mass, and improved systolic and diastolic tissue Doppler velocities. Despite its high attrition rates, our study provides the first experimental human evidence suggesting that preconception lifestyle interventions may present a method of reducing CVD risk in the next generation. CLINICAL TRIAL REGISTRATION: LIFEstyle study: Netherlands Trial Register: NTR1530 ( https://www.trialregister.nl/trial/1461 ). This follow-up study was approved by the medical ethics committee of the University Medical Centre Groningen (METC code: 2008/284).
BACKGROUND: Improving maternal lifestyle before conception may prevent the adverse effects of maternal obesity on their children's future cardiovascular disease (CVD) risk. In the current study, we examined whether a preconception lifestyle intervention in women with obesity could alter echocardiographic indices of cardiovascular health in their children. METHODS: Six years after a randomized controlled trial comparing the effects of a 6-month preconception lifestyle intervention in women with obesity and infertility prior to fertility care to prompt fertility care, 315 of the 341 children conceived within 24 months after randomization were eligible for this study. The intervention was aimed at weight loss (≥5% or until BMI < 29 kg/m2). Children underwent echocardiographic assessment of cardiac structure and function, conducted by a single pediatric cardiologist, blinded to group allocation. Results were adjusted for multiple variables including body surface area, age, and sex in linear regression analyses. RESULTS: Sixty children (32 girls, 53%) were included, mean age 6.5 years (SD 1.09). Twenty-four children (40%) were born to mothers in the intervention group. Children of mothers from the intervention group had a lower end-diastolic interventricular septum thickness (-0.88 Z-score, 95%CI -1.18 to -0.58), a lower left ventricle mass index (-8.56 g/m2, 95%CI -13.09 to -4.03), and higher peak systolic and early diastolic annular velocity of the left ventricle (1.43 cm/s 95%CI 0.65 to 2.20 and 2.39 cm/s 95%CI 0.68 to 4.11, respectively) compared to children of mothers from the control group. CONCLUSIONS: Children of women with obesity, who underwent a preconception lifestyle intervention, had improved cardiac structure and function; a thinner interventricular septum, lower left ventricle mass, and improved systolic and diastolic tissue Doppler velocities. Despite its high attrition rates, our study provides the first experimental human evidence suggesting that preconception lifestyle interventions may present a method of reducing CVD risk in the next generation. CLINICAL TRIAL REGISTRATION: LIFEstyle study: Netherlands Trial Register: NTR1530 ( https://www.trialregister.nl/trial/1461 ). This follow-up study was approved by the medical ethics committee of the University Medical Centre Groningen (METC code: 2008/284).
Authors: Yan Huang; Xu Yan; Jun X Zhao; Mei J Zhu; Richard J McCormick; Stephen P Ford; Peter W Nathanielsz; Jun Ren; Min Du Journal: Am J Physiol Endocrinol Metab Date: 2010-09-28 Impact factor: 4.310
Authors: Rebecca M Reynolds; Keith M Allan; Edwin A Raja; Sohinee Bhattacharya; Geraldine McNeill; Philip C Hannaford; Nadeem Sarwar; Amanda J Lee; Siladitya Bhattacharya; Jane E Norman Journal: BMJ Date: 2013-08-13
Authors: Heather L Blackmore; Youguo Niu; Denise S Fernandez-Twinn; Jane L Tarry-Adkins; Dino A Giussani; Susan E Ozanne Journal: Endocrinology Date: 2014-07-22 Impact factor: 4.736
Authors: Elena Loche; Heather L Blackmore; Asha A Carpenter; Jessica H Beeson; Adele Pinnock; Thomas J Ashmore; Catherine E Aiken; Juliana de Almeida-Faria; Josca M Schoonejans; Dino A Giussani; Denise S Fernandez-Twinn; Susan E Ozanne Journal: Cardiovasc Res Date: 2018-08-01 Impact factor: 10.787